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A 65-year-old male p a t i e n t of m i n e wi th a past
medical history of t rans ient ischaemic a t tacks recently
developed epigastric pain. He has been on soluble aspirin
and endoscopy which confirmed a smal l peptic ulcer.
How should 1 manage this patient?
Comments:
This pat ient presents w i t h two separate problems
which pose p o t e n t i a l t h rea t s : t r a n s i e n t i schaemic
attack(s), and uncomplicated peptic ulcer disease, linked
by association with aspirin therapy.
Ant ip la te le t therapy, p r i n c i p a l l y aspi r in , is the
recommended t rea tment for pa t ien ts wi th transient
ischaemic attacks and non-disabling strokes with proven
ef f icacy in r educ ing the inc idence of stroke and
cardiovascular deaths. This patient should also be
investigated w i th a carotid duplex scan to exclude
s i g n i f i c a n t e x t r a c r a n i a l a r te ry disease. Several
multicenter randomized trials,1'2 for example the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET),1 has demonstrated that patients with transient
ischaemic attacks with corresponding carotid stenosis of
greater than 70% benefit from carotid endarterectomy
compared with medical treatment alone. With improving
duplex technology and a good q u a l i t y v a s c u l a r
technologist, carotid endarterectomy can be performed on
duplex criteria alone without arteriogram.
The two major causes of peptic ulcer disease include
Helicobacter pylori and non-steroidal anti-inflammatory
drugs (NSAIDs). The National Institutes of Health
Consensus Development Conference has recommended
the addition of antimicrobial agents to antisecretory drugs
to treat all patients with H. pylori-associated peptic ulcer
disease.3 To date, one of the best regimens for eradicating
H. pylori is a one-week course of t r i p l e the rapy
containing a proton pump inhibitor and two antibiotics.4
The interaction between H. pylori and NSAIDs in peptic
ulcer disease is currently unsettled.
Two large, randomized, double-blind, multicenter,
controlled studies (Acid Suppression Trial: Ranitidine
versus Omeprazo le for NSAID-Assoc ia ted Ulcer
Treatment [ASTRONAUT] 5 and Omeprazole versus
Misoprostol for NSAID-Induced Ulcer Management
[OMNIUM]6 ' have recently been published addressing the
issue of treatment and prophylaxis of NSAID-associated
peptic ulcer disease. The trials examined the efficacy of
omeprazole, 20 mg and 40 mg once daily, compared with
ranitidine5 or misoprostol,6 for the healing of peptic ulcer
disease (gastric or duodenal ulcers or > 10 erosions) in
patients who required, and continued to receive NSAIDs.
Both studies reported superior results (77%) in treatment
success (ulcer healing and relief of dyspeptic symptoms)
by a four to eight weeks regime with both doses of
omeprazole compared w i t h r a n i t i d i n e (63%) or
misoprostol (71%). In the patients who had a duodenal
ulcer and taking NSAIDs, 93% of the ulcers were
reported healed at eight weeks with omeprazole 20 mg
once a day. Duodenal ulcers, small ulcers, and positive
tests for H. pylori were favourable factors for overall
treatment success. The treatment was also well tolerated.
The same studies also assigned patients who had
their ulcers successful ly healed to a maintenance
treatment with omeprazole 20 mg daily compared with
ranitidine or misoprostol, and again a lower relapse rate
was reported with omeprazole, where 60-70% of patients
taking the proton pump inhibitor remained in remission
at the end of six months.
With this background, omeprazole, 20 mg daily
should be the treatment of choice for healing the duodenal




followed with a course of maintenance with omeprazole,
and aspirin should be continued for its demonstrated
benefits for cerebrovascular disease. The presence or
absence of extracranial carotid disease should be
documented with a carotid duplex ultrasound to correlate
with the symptoms of transient ischaemic attack. Should
a high-grade (>70%) carotid stenosis be identified,
carotid endarterectomy has been shown to carry a distinct
b e n e f i t i n s t r o k e - f r e e s u r v i v a l and s h o u l d be
recommended. •
The comments have
been prepared by: Dr S W K Cheng, MS, FRCS, FACS
Associate Professor in Surgery
The University of Hong Kong
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